ALBI versus Child‐Pugh grading systems for liver function in patients with hepatocellular carcinoma

Background The prognostic performance of the albumin‐bilirubin (ALBI) grade in hepatocellular carcinoma (HCC) as an objective method of assessing liver function was investigated. Methods Data from 2099 patients with HCC in Korea were collected and analyzed retrospectively. The discriminative performance of ALBI grade was compared with Child‐Pugh (C‐P) grade for different stages or treatments. Results The median follow up duration was 16.2 months (range: 1.0‐124.9). The median survival times were 49.7 months for C‐P grade A (65.8%), 12.4 months for C‐P grade B (25.5%), and 4.2 months for C‐P grade C (8.6%) (P